Review Article
Headache in Pregnancy: A Nuisance or a New Sense?
Table 2
Drugs commonly used for treatment and/or prophylaxis of migraine and their FDA rating and fetomaternal effects.
| Drug | FDA rating | Maternal effects | Fetal effects | Compatible with breastfeeding |
| Paracetamol | B | Medication overuse | None | Yes | Opioids | B/C | Overuse/dependence Constipation | ??cleft palate/inguinal hernia | Yes | Aspirin | C | Increased risk bleeding | Narrowing of ductus arteriosus | Yes | NSAIDs | B/D | Inhibition of implantation | Premature closure of ductus arteriosus Restriction of renal blood flow NEC and IVH in preterm foetuses | Yes | Triptans | C | Limited evidence possible increased miscarriage | ?Preterm birth and IUGR | ?? | Antiemetics | B/C | None | None | Yes | Caffeine | B | Overuse/withdrawal headache | NoneHigh doses—miscarriage, IUGR | Yes | Ergot alkaloids | X | Uterine hypercontractility Reduced placental perfusion | Miscarriage Fetal compromise Intestinal atresia | No | Beta blockers | B/C | None | ?IUGR, fetal bradycardia | Yes | Antiepileptics | C/D | None | Malformations | Yes | Antidepressants | B/C | None | High doses—neonatal depression, irritability, spasms, or convulsions | Caution |
|
|